- All the health insurers are going to raise prices starting 2026 which should improve the margins of healthcare insurers starting 2026
- We have only 3 months left to load up before fundamentals starts improving and start showing up in the numbers of earning reports.
- All the analyst estimates which have been lowered in last 6 months will be incorrect and
UNH should comfortably beat those which will lead to re-rating of the stock and eventually it should trade above 450+ before June 2026
- We have only 3 months left to load up before fundamentals starts improving and start showing up in the numbers of earning reports.
- All the analyst estimates which have been lowered in last 6 months will be incorrect and
הערה
Point target # 1 : 350Point target #2 : 380
Point target # 3: 400
Point target # 4: 450
Point target # 5: 500
הערה
- I am hopeful that we should reach above point target #2 before end of the year! i.e $380+הערה
- Solid display of strength on red bloodshed day in the marketהערה
- Please note that - Secondly,
careers.unitedhealthgroup.com/job-search-results/?keyword=data science
הערה
There are three main tailwinds for - Premium increase so that they can offset their losses because of higher MLR ratio
- AI/ML projects would lead to operational efficiency at scale
- Seasoned leadership who has decade of experience leading the
- There are lot of companies which will have slowdown in growth in 2026 whereas
- Market is almost at all time highs, any fear in the market will lead to money rotating to defensive sector of the market. Therefore, risk/return favours staying long
הערה
- On September 8, 2025 : SMA (7) is about to cross SMA (100) which shows that bullish momentum is building and Bulls are in control. הערה
- Don't be scared, ride the momentum, rally has legs as it's still very undervalued. - Re-pricing will lead to massive offset to the losses and will improve margins.
-
-
הערה
- You know what the best thing about today's move? market cap is still pretty low for - Long way to go! Anything under 500B for this company is unjustified
הערה
הערה
- כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.